Devices › Heart-valve, non-allograft tissue
Device brand name · Heart-valve non-allograft tissue
MITRIS RESILIA Mitral Valve: medical device reports filed with FDA
184 reports name it, 2022–2026. Manufacturer given most often on reports: Edwards Lifesciences. Product code LWR.
- 184
- device reports naming the brand
- 0% of all MAUDE reports · about 46 a year
- 57
- reports, 12 months to August 2026
- 59 in the 12 months before
- 1.1%
- classified as malfunction
- 4.9% across the product code
- 3.8%
- classified as death, as reported
- 7 reports · not verified by FDA
184 medical device reports received by FDA name the brand "MITRIS RESILIA Mitral Valve" (heart-valve non-allograft tissue); the manufacturer given most often on reports is Edwards Lifesciences; received from July 2022 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
57 reports arrived in the 12 months to August 2026, close to the 59 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (95.1%), death (3.8%) and malfunction (1.1%); across all heart-valve, non-allograft tissue reports (product code LWR) death is recorded in 8% and malfunction in 4.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (47.3%), patient device interaction problem (15.2%) and intravalvular regurgitation (7.1%). The patient problems coded most often are endocarditis, heart failure/congestive heart failure and thrombosis/thrombus. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 25,638 reports carrying product code LWR. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 87 | 47.3% | 25.2% |
| Patient device interaction problem | 28 | 15.2% | 3.5% |
| Intravalvular regurgitation | 13 | 7.1% | 4.4% |
| Fluid/blood leak | 12 | 6.5% | 1.3% |
| Calcified | 11 | 6% | 5.7% |
| Patient-device incompatibilitythe device did not suit the patient | 10 | 5.4% | 2.5% |
| Degraded | 9 | 4.9% | 3.7% |
| Perivalvular leak | 9 | 4.9% | 6% |
| Device stenosis | 5 | 2.7% | 4.1% |
| Gradient increase | 5 | 2.7% | 6.1% |
| Device dislodged or dislocated | 4 | 2.2% | 0.4% |
| Entrapment of device | 4 | 2.2% | 0% |
| Mechanical jam | 4 | 2.2% | 0.1% |
| Thickening of material | 4 | 2.2% | 0.2% |
| Difficult to open or close | 3 | 1.6% | 0.5% |
| Material split, cut or torn | 2 | 1.1% | 3.6% |
| Breakthe device broke | 1 | 0.5% | 0.3% |
| Detachment of device or device componentpart of the device came off | 1 | 0.5% | 0.4% |
| Difficult or delayed positioning | 1 | 0.5% | 0% |
| Incomplete coaptation | 1 | 0.5% | 3.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Endocarditis | 26 | 14.1% |
| Heart failure/congestive heart failure | 18 | 9.8% |
| Thrombosis/thrombus | 18 | 9.8% |
| Rupturethe device burst | 11 | 6% |
| Dyspneashortness of breath | 10 | 5.4% |
| Cardiogenic shockshock from the heart failing to pump | 3 | 1.6% |
| Aortic valve insufficiency/ regurgitation | 2 | 1.1% |
| Cardiomyopathydisease of the heart muscle | 2 | 1.1% |
| Chillschills or shivering | 2 | 1.1% |
| Hemorrhage/blood loss/bleeding | 2 | 1.1% |
| Air embolism | 1 | 0.5% |
| Anemialow red blood cells | 1 | 0.5% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 1 | 0.5% |
| Arrhythmia | 1 | 0.5% |
| Chest painchest pain | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | MITRIS RESILIA Mitral Valve | Product code LWR | All MAUDE reports |
|---|---|---|---|
| Reports | 184 | 25,638 | 26,136,888 |
| Share of that pool | — | 0.7% | 0% |
| Classified as death, per 1,000 reports | 38 | 80 | 9 |
| Classified as injury | 95.1% | 86.2% | 36.2% |
| Classified as malfunction | 1.1% | 4.9% | 62.3% |
| Filed by the manufacturer | 99.5% | 95.7% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LWR
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Freestyle Aortic Root Bioprosthesis | 2,344 | 202 | 6% |
| Edwards INSPIRIS RESILIA Aortic Valve | 2,035 | 599 | 0.8% |
| Sjm Trifecta Valve | 1,525 | 0 | 8.1% |
| Perceval Sutureless Aortic Heart Valve | 1,473 | 18 | 9.1% |
| Mosaic Aortic Bioprosthetic Heart Valve | 3,406 | 405 | 2.8% |
| Carpentier-Edwards Perimount Pericardial Bioprosthesis | 978 | 1 | 10% |
| Carpentier-Edwards Bioprosthesis | 1,055 | 3 | 5% |
| Mosaic Mitral Bioprosthetic Heart Valve | 1,534 | 154 | 6.4% |
| Carpentier-Edwards PERIMOUNT Plus Pericardial Bioprosthesis | 2,878 | 18 | 8.7% |
| Carpentier-Edwards Perimount Magna Aortic Bioprosthesis | 1,324 | 11 | 27.1% |
| Carpentier-Edwards Perimount Rsr Pericardial Bioprosthesis | 3,288 | 13 | 3.3% |
| Trifecta GT Valve | 674 | 66 | 9.5% |
| EDWARDS INTUITY ELITE Valve System | 677 | 62 | 2.2% |
| Avalus Aortic Tissue Valve | 652 | 133 | 11% |
| INSPIRIS RESILIA Aortic Valve | 532 | 87 | 0.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about MITRIS RESILIA Mitral Valve reports
How many FDA reports name MITRIS RESILIA Mitral Valve?
184 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 57 in the latest 12 months.
What kinds of events are reported?
injury (95.1%), death (3.8%) and malfunction (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (47.3%), patient device interaction problem (15.2%), intravalvular regurgitation (7.1%), fluid/blood leak (6.5%) and calcified (6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that MITRIS RESILIA Mitral Valve was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.